My watch list
my.bionity.com  
Login  
Müllerstr. 178
13353 Berlin
Germany
Tel.
+49304681111
Fax
+493046815305

Company Portrait

Bayer Schering Pharma’s goal is a leading market position in each of its specialist fields. With its distinctive expertise, the company engages in research on new drugs which, as innovative therapies, make an essential contribution toward improving people’s quality of life. Our outstanding research activities, together with our highly motivated staff, secure the sustainable success and growth of our company.

Our universally valid corporate values require that every individual respects humankind, nature and the community, accepts the diversity of life, and follows the highest standards of ethics and quality. These include integrity, openness, honesty, the will to succeed, and aspects of sustainability.

Focus: Manufacturer

Industrial Sectors

  • Pharma

Contact / Request information

Contact the company and request further information free of charge:

Watchlist

This is where you can add this company to your personal favourites

More about Bayer Schering Pharma
  • News

    Lead Discovery Center and Bayer enter into license agreement covering a novel pharmaceutical lead structure

    The Lead Discovery Center GmbH (LDC), based in Dortmund, Germany, a spin-off from Max-Planck-Innovation GmbH (MI) in Munich, with expertise in small molecule pharmaceutical drug discovery, has successfully licensed its first lead structure to a pharma partner. The agreement grants Bayer Sch ... more

    EU regulators okay Qlaira for the treatment of heavy menstrual bleeding

    Bayer Schering Pharma AG, Germany, has successfully concluded the European registration procedure for the introduction of Qlaira in the new indication treatment of heavy menstrual bleeding in women without organic pathology who desire oral contraception. The Netherlands served as Reference ... more

    Bayer launches Betaferon in China

    Bayer Schering Pharma announced the upcoming launch in China of Betaferon® (interferon beta-1b) for the treatment of relapsing-remitting forms of multiple sclerosis (MS). Betaferon is already approved in over 100 countries worldwide. With Betaferon and Gadovist®1.0, which was also recently ... more

  • Companies

    Bayer Schering Pharma AG

    Bayer Schering Pharma’s goal is a leading market position in each of its specialist fields. With its distinctive expertise, the company engages in research on new drugs which, as innovative therapies, make an essential contribution toward improving people’s quality of life. Our outstanding ... more

    Bayer Schering Pharma Oy

    Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more

    Bayer Schering Pharma AG

    Bayer Schering Pharma’s goal is a leading market position in each of its specialist fields. With its distinctive expertise, the company engages in research on new drugs which, as innovative therapies, make an essential contribution toward improving people’s quality of life. Our outstanding ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE